The role of robotics in the treatment of NSCLC

Katarzyna Furrer (Basel, Switzerland)

Source: International Congress 2015 – Robotics in pulmonology and thoracic surgery
Session: Robotics in pulmonology and thoracic surgery
Session type: Symposium
Number: 454
Disease area: Thoracic oncology

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Katarzyna Furrer (Basel, Switzerland). The role of robotics in the treatment of NSCLC. International Congress 2015 – Robotics in pulmonology and thoracic surgery

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of robotic surgical management in early stage lung cancer
Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
Year: 2020


NSCLC management
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

NSCLC management
Source: ERS Skills Course 2016
Year: 2016

NSCLC management
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

NSCLC management
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Role of adjuvant/neoadjuvant treatment in stage I NSCLC
Source: International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Year: 2014



Pulmonologists and lung cancer: pivotal role in multidisciplinary approach
Source: Eur Respir J 2013; 42: 1183-1185
Year: 2013


The role of radiation therapy in the management of small cell lung cancer
Source: Breathe, 13 (4) e87; 10.1183/20734735.009617
Year: 2017



Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007


The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting
Source: Eur Respir J 2002; 20: Suppl. 38, 399s
Year: 2002

Albumin-bound paclitaxel (nab-P) may play an important role in the treatment of non-small-cell lung cancer (NSCLC) patients
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011



Reflex testing  is crucial for treatment decisions in advanced non small cell lung cancer (NSCLC)
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017

Treatment of advanced non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005